(Q36872323)

16 August 2017

Peptide mimics of a conformationally constrained protective epitopes of respiratory syncytial virus fusion protein (English)

1 reference

16 August 2017

Chargelegue D

1

1 reference

16 August 2017

Obeid OE

2

1 reference

16 August 2017

Shaw DM

3

1 reference

16 August 2017

Denbury AN

4

1 reference

16 August 2017

Hobby P

5

1 reference

16 August 2017

Hsu SC

6

1 reference

16 August 2017

Steward MW

7

1 reference

16 August 2017

1 June 1997

1 reference

16 August 2017

1 reference

16 August 2017

57

1 reference

16 August 2017

1-3

1 reference

16 August 2017

15-17

1 reference

Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Prospects for a respiratory syncytial virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

The pharmacokinetics, antigenicity, and fusion-inhibition activity of RSHZ19, a humanized monoclonal antibody to respiratory syncytial virus, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Conformational constraints of conserved neutralizing epitopes from a major antigenic area of human respiratory syncytial virus fusion glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Searching for Peptide Ligands with an Epitope Library

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Phage Peptide Libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

A new type of synthetic peptide library for identifying ligand-binding activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

A One-Bead One-Peptide Combinatorial Library Method for B-Cell Epitope Mapping

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Identification of HIV vaccine candidate peptides by screening random phage epitope libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Identification of the core residues of the epitope of a monoclonal antibody raised against glycoprotein D of herpes simplex virus type 1 by screening of a random peptide library

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Permissive residues within the minimal epitopes of neutralizing monoclonal antibodies to the V3 loop of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Recognition by human sera and immunogenicity of HBsAg mimotopes selected from an M13 phage display library.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900045-X

7 January 2021

10.1016/S0165-2478(97)00045-X

Identifiers

DOI

1 reference

release_ku7hc6qzmzdx7cxuilkffzh6fe

16 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ku7hc6qzmzdx7cxuilkffzh6fe

24 November 2022

mapped directly with Wikidata item

1 reference